Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company, in collaboration with Chinese partners, has announced the launch of a major investment project. The parties have agreed to build a new facility for the production of pharmaceutical substances, which will be located in the Irkutsk region.
The total cost of the project is estimated at 13.06 billion tenge. This cooperation is aimed at developing domestic production of medicinal components, which is an important step toward ensuring the country's medical security.
The new plant will make it possible to establish the production of raw materials necessary for creating finished medicinal products. Utilizing Chinese technology and Russian production potential will help reduce dependence on imports in the pharmaceutical industry.
Construction of the facility is planned to begin in the near future. It is expected that the implementation of this project will create new jobs in the region and strengthen economic ties between Russia and China in the fields of high technology and medicine.